Good Prognostic Value of Increased Lymph Node Yield in Locally Advanced Rectal Cancer with Neoadjuvant Chemoradiotherapy
Y. Wang,M. Zhou,L. Yang,J. Zhang,W. Deng,L. Shen,L. Liang,W. Yang,R. Hu,J. Zhu,Z. Zhang
DOI: https://doi.org/10.1016/j.ijrobp.2018.07.051
2018-01-01
Abstract:It is recommended that a lymph node yield (LNY) of at least 12 is necessary to confirm node-negative disease for colorectal cancer. However, it is debated whether this threshold is applicable to locally advanced rectal cancer (LARC) with neoadjuvant chemoradiation (neo-CRT) and the association between LNY and survival is not clear. Some studies showed that a LNY of less than 12 was related to good tumor response. This study aimed to examine factors associated with LNY and its prognostic significance in those patients. Between 2006 and 2014, 495 LARC patients following neo-CRT and surgery were retrospectively analyzed. Clinicopathological features, overall survival (OS), disease free survival (DFS), local recurrence free survival (LRFS) and distant metastasis free survival (DMFS) were recorded. The patients were separated into two groups: LNY < 12 group and LNY ≥ 12 group. The chi-square test was used to compare differences in the distributions of the clinicopathological variables by LNY group. Univariate and multivariate analyses were performed using the Kaplan-Meier method and the Cox proportional hazards regression in all patients. Subgroup analyses were done according to status of lymph node metastasis and grade of tumor regression. Of the 495 patients, a LNY of less than 12 were found in 287 (57.98%) patients. There were no significant differences in the distributions of the clinicopathological variables by LNY group, including age, gender, distance from anus, type of surgical procedure, tumor grade, cTNM staging and ypTNM staging (all P>0.05). In addition, no association was found between LNY group and tumor regression grade (TRG) (P = 0.499). Kaplan-Meier method and univariate analysis showed that LNY ≥ 12 group had better OS (P = 0.030), DFS (P = 0.012) and DMFS (P = 0.011) compared with LNY < 12 group, but not LRFS (P = 0.293). In multivariate analysis, LNY ≥ 12 was an independent good prognostic factor of OS (HR 0.522, 95%CI 0.338-0.804, P = 0.003), DFS (HR 0.595, 95%CI 0.430-0.823, P = 0.002) and DMFS (HR 0.583, 95%CI 0.398-0.853, P = 0.005) in all patients, but not LRFS (HR 0.597, 95%CI 0.326-1.091, P = 0.093). However, subgroup analyses showed that LNY had no association with prognosis (OS, LRFS, DMFS, DFS, all P > 0.05) in patients with negative lymph nodes or patients with good tumor response (TRG = 0 and 1). Increased lymph node yield (LNY ≥ 12) was an independent good prognostic factor in locally advanced rectal cancer with neoadjuvant chemoradiation, and lower lymph node yield (LNY < 12) is not associated with good tumor response. It indicates that these patients probably still need enough number of lymph node yield (≥ 12) even though they received neoadjuvant chemoradiation.